Apollo Hospitals Gains 3.44%: 7 Key Factors Driving the Week’s Momentum

18 May: Week Begins with Slight Decline Amid Market Weakness

Apollo Hospitals opened the week at Rs.8,021.10, registering a decline of 0.75% on 18 May 2026. This drop was in line with the broader market, as the Sensex fell 0.35% to 35,114.86. The stock’s volume was moderate at 15,780 shares, reflecting cautious investor sentiment at the start of the week. Despite the dip, the stock remained well above key moving averages, setting the stage for a potential rebound.

19 May: Modest Recovery with Positive Market Sentiment

On 19 May, Apollo Hospitals edged higher by 0.06% to close at Rs.8,026.00, marginally outperforming the Sensex’s 0.25% gain. The volume declined to 7,697 shares, but delivery volumes increased by 15.19% compared to the five-day average, signalling growing investor conviction. The stock’s resilience amid a recovering market hinted at underlying strength ahead of more significant moves.

20 May: Sharp Open Interest Surge Signals Bullish Market Positioning

Apollo Hospitals witnessed a notable surge in open interest in its derivatives segment on 20 May, with contracts rising 12.28% to 38,220. This increase accompanied a strong volume of 56,040 contracts and a combined futures and options value exceeding ₹34,000 crores, underscoring heightened market activity. The stock gained 0.91% to Rs.8,098.65, outperforming the hospital sector and Sensex. Technical indicators showed the stock trading above all key moving averages, reinforcing a bullish setup.

21 May: New 52-Week High and Robust Institutional Interest

The stock surged 2.54% to Rs.8,304.10 on 21 May, hitting a new 52-week high of Rs.8,274.95 intraday. This marked the third consecutive day of gains, with a cumulative return of 4.51% over the period. Trading volume soared to 102,878 shares, with delivery volumes up 38.11%, signalling strong institutional participation. Apollo Hospitals emerged as one of the most actively traded stocks by value, with a turnover of approximately ₹439.85 crores. The stock outperformed the hospital sector by 0.62% and the Sensex by 0.42%, reflecting its leadership position.

Derivatives activity intensified, with open interest rising 12.86% to 44,588 contracts and call option volumes surging at strike prices above the current market level, indicating bullish sentiment. Put option activity was also heavy at strikes below the market price, suggesting active hedging amid the rally. The stock maintained its position above all key moving averages, supported by strong technical indicators such as MACD and Bollinger Bands.

22 May: Continued Momentum with Another 52-Week High

Apollo Hospitals extended its rally on 22 May, closing at a fresh 52-week high of Rs.8,417.50, up 1.38% from the previous close. The stock outperformed its sector peers by 1.14% and the Sensex by 0.52%, which closed at 75,570.95. This marked the fourth consecutive day of gains, delivering a cumulative return of 6.9% since 19 May. The company’s mojo score improved to 78.0, reinforcing its Buy rating. Financial metrics such as a ROCE of 17.13%, operating profit margins near 39%, and consistent quarterly earnings growth underpin the stock’s strong fundamentals.

Weekly Price Performance: Apollo Hospitals vs Sensex

Key Takeaways from the Week

1. Strong Price Momentum: Apollo Hospitals gained 3.44% over the week, significantly outperforming the Sensex’s 0.50% rise, reflecting robust investor demand and sector leadership.

2. Derivatives Market Activity: Sharp increases in open interest and call option volumes at strikes above the current price indicate bullish market positioning, while heavy put option activity suggests active hedging rather than bearish sentiment.

3. Institutional Confidence: Delivery volumes surged by over 38%, and the stock emerged as one of the most actively traded by value, signalling strong institutional participation and conviction.

4. Technical Strength: The stock consistently traded above all key moving averages, with technical indicators such as MACD and Bollinger Bands supporting sustained upward momentum.

5. Financial Fundamentals: Record quarterly results, high ROCE (above 17%), and consistent earnings growth underpin the stock’s rally and justify its upgraded mojo rating to 78.0 (Buy).

6. Valuation Attractiveness: Despite premium multiples, Apollo Hospitals’ valuation metrics remain reasonable relative to peers, supported by strong returns on equity and capital employed.

7. Sector Leadership: With a market capitalisation exceeding Rs.1,19,000 crore and commanding nearly 20% of the hospital sector’s market value, Apollo Hospitals continues to dominate its industry segment.

Conclusion

Apollo Hospitals Enterprise Ltd. demonstrated a compelling combination of price appreciation, strong derivatives market activity, and solid fundamentals during the week ending 22 May 2026. The stock’s ability to consistently outperform the Sensex and its sector peers, coupled with rising institutional interest and an upgraded mojo rating, highlights its status as a leading healthcare investment. While the surge in put options suggests prudent hedging, the overall market positioning remains bullish, supported by robust technical indicators and record financial performance. Investors should monitor ongoing volume trends and price action as the stock approaches key resistance levels, but the current momentum and valuation shifts signal a favourable environment for Apollo Hospitals in the near term.

Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →